Wordsworth, P., Dijkmans, B., van der Heijde, D., Davis, J., Schiff, M., Kivitz, A., . . . Grp, A. (2008). Adalimumab sustains improvement in spinal mobility in as patients through 104 weeks - Results from atlas.
Čikaški stil citiranja (17. izdanje)Wordsworth, P., et al. Adalimumab Sustains Improvement in Spinal Mobility in as Patients Through 104 Weeks - Results from Atlas. 2008.
MLA način citiranja (9. izdanje)Wordsworth, P., et al. Adalimumab Sustains Improvement in Spinal Mobility in as Patients Through 104 Weeks - Results from Atlas. 2008.
Upozorenje: Ovi citati možda nisu uvijek 100% točni.